Lipoprotein lipase gene variants and the effect of environmental factors on cardiovascular disease risk

Diabetes, Obesity and Metabolism

Volumn 6, Issue 1, 2004, Pages 1-7

  Talmud, Philippa J ^a   Stephens, Jeffrey W ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Gene environment interaction; Genetic polymorphisms; Lipoprotein lipase

Indexed keywords

LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; DRUG TARGETING; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; HYPERLIPOPROTEINEMIA TYPE 1; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LIFESTYLE; MORTALITY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; REVIEW; SMOKING;

EID: 0742289443     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2004.00304.x     Document Type: Review

References (29)

1. Beisiegel U, Weber W, Bengtsson-Olivecrona G. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc Natl Acad Sci USA 1991; 88: 8342-8346.
2. Clee SM, Bissada N, Miao F et al. Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis. J Lipid Res 2000; 41: 521-531.
3. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3: 213-219.
4. Yao M, Lichtenstein AH, Roberts SB et al. Relative influence of diet and physical activity on cardiovascular risk factors in urban Chinese adults. Int J Obes Relat Metab Disord 2003; 27: 920-932.
5. Eliasson B, Mero N, Taskinen MR, Smith U. The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis 1997; 129: 79-88.
6. Craig WY, Palomaki GE, Johnson AM, Haddow JE. Cigarette smoking-associated changes in blood lipid and lipoprotein levels in the 8- to 19-year-old age group: a meta-analysis. Pediatrics 1990; 85: 155-158.
7. Ginsberg HN, Kris-Etherton P, Dennis B et al. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects. The DELTA Study, protocol 1. Arterioscler Thromb Vasc Biol 1998; 18: 441-449.
8. Doll R, Hill AB. Mortality of British doctors in relation to smoking; observation on coronary thrombosis. In: Haenzel W, ed. Epidemiological approaches to the study of cancer and other chronic diseases. National Cancer Institute Monograph Number 19. US Department of Health Education and Welfare, 1966: 205-268.
9. Savolainen MJ, Kesaniemi YA. Effects of alcohol on lipoproteins in relation to coronary heart disease. Curr Opin Lipidol 1995; 6: 243-250.
10. Haskell WL. The influence of exercise training on plasma lipids and lipoproteins in health and disease. Acta Med Scand Suppl 1986; 711: 25-37.
11. Allen DR, Browse NL, Rutt DL, Butler L, Fletcher C. The effect of cigarette smoke, nicotine, and carbon monoxide on the permeability of the arterial wall. J Vasc Surg 1988; 7: 139-152.
12. Dalmon J, Laurent M, Courtois G. The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element. Mol Cell Biol 1993; 13: 1183-1193.
13. Meade TW, Mellows S, Brozovic M et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-537.
14. Fickl H, Van Antwerpen VL, Richards GA et al. Increased levels of autoantibodies to cardiolipin and oxidised low density lipoprotein are inversely associated with plasma vitamin C status in cigarette smokers. Atherosclerosis 1996; 124: 75-81.
15. Brunzell JD. Familial lipoprotein lipase deficiency and other causes of the chylomicromemia syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Molecular Basis of Inherited Disease. New York: McGraw-Hill 1989, 1165-1180.
16. Ma Y, Henderson HE, Murphy MRV et al. A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians. N Engl J Med 1991; 324: 1761-1766.
17. Mailly F, Palmen J, Talmud PJ et al. Familial lipoprotein lipase (LPL) deficiency: a catalogue of LPL gene mutations identified in twenty patients from the UK, Sweden and Italy. Hum Mutat 1997; 10: 465-473.
18. Fisher RM, Humphries SE, Talmud PJ. Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis. Atherosclerosis 1997, 135: 145-159.
19. Mailly F, Tugrul Y, Reymer PWA et al. A common variant in the gene for lipoprotein lipase (Asp9 → Asn): functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscler Thromb Vasc Biol 1995; 15: 468-478.
20. Zhang H, Henderson H, Gagne SE et al. Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function. Biochim Biophys Acta 1996; 1302: 159-166.
21. Fisher RM, Benhizia F, Schreiber R et al. Enhanced bridging function and augmented monocyte adhesion by lipoprotein lipase N9: insights into increased risk of coronary artery disease in N9 carriers 1. Atherosclerosis 2003; 166: 243-251.
22. Hokanson JE. Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studies. Int J Clin Lab Res 1997; 27: 24-34.
23. Wittrup HH, Tybjaerg Hansen A, Nordestgaard BG. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation 1999; 99: 2901-2907.
24. Kastelein JJ, Ordovas JM, Wittekoek ME et al. Two common mutations (D9N, N291S) in lipoprotein lipase: a cumulative analysis of their influence on plasma lipids and lipoproteins in men and women. Clin Genet 1999; 56: 297-305.
25. Talmud PJ, Bujac S, Hall S, Humphries SE, Miller GJ. Substitution of asparagine for aspartic acid at residue 9 (D9N) of lipoprotein lipase markedly augments risk of coronary heart disease in male smokers. Atherosclerosis 2000; 149: 75-81.
26. Miller GJ, Bauer KA, Barzegar S, Cooper JA, Rosenberg RD. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease. Thromb Haemost 1996; 75: 767-771.
27. Saxena U, Witte LD, Goldberg IJ. Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids. J Biol Chem 1989; 8: 4349-4355.
28. Obunike JC, Paka S, Pillarisetti S, Goldberg IJ. Lipoprotein lipase can function as a monocyte adhesion protein. Arterioscler Thromb Vasc Biol 1997; 17: 1414-1420.
29. Hendriks WL, van der Boom H, van Vark LC, Havekes LM. Lipoprotein lipase stimulates the binding and uptake of moderately oxidized low-density lipoprotein by J774 macrophages. Biochem J 1996; 314: 563-568.